• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004年从77个中心获得的18639株临床分离菌对左氧氟沙星及多种抗菌药物的体外敏感性

[In-vitro susceptibilites to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004].

作者信息

Yamaguchi Keizo, Ohno Akira, Ishii Yoshikazu, Tateda Kazuhiro, Iwata Morihiro, Kanda Makoto, Tsujio Yoshiko, Kimoto Hiroya, Kaimori Mitsuomi, Nakamura Toshihiko, Kawamura Chizuko, Nishimura Masaharu, Akizawa Koji, Katayama Yosei, Matsuda Keiko, Hayashi Tasuku, Yasujima Minoru, Kasai Takeshi, Kimura Masahiko, Tominaga Makoto, Miki Makoto, Nakanowatari Susumu, Nakagawa Takuo, Kaku Mitsuo, Kanemitsu Keiji, Kunishima Hiroyuki, Toyoshima Shunkoh, Sakurai Masanori, Shiotani Joji, Sugita Akihiro, Ito Tatsumi, Okada Jun, Suwabe Akira, Yamahata Kumiko, Yoneyama Akiko, Kumasaka Kazunari, Yamane Nobuo, Koike Kazuhiko, Ieiri Tamio, Kominami Hidenori, Yamada Toshiyuki, Oguri Toyoko, Itoh Kouichi, Watanabe Kiyoaki, Kobayashi Yoshio, Ohtake Teruko, Uchida Takashi, Totsuka Kyoichi, Murakami Masami, Yomoda Sachie, Takahashi Ayako, Okamoto Hideyuki, Inuzuka Kazuhisa, Yamazaki Kenichiro, Gonda Hideo, Yamashita Takanori, Yamaguchi Ikuo, Okada Motoi, Ikari Hiromi, Kurosawa Naomi, Fujimoto Yoshinori, Ishigo Shiomi, Asano Yuko, Mikio Mori, Kano Ichino, Nagano Eiko, Kageyama Fumio, Shaku Etsuko, Kanno Harushige, Aihara Masanori, Gemma Hitoshi, Uemura Keiichi, Miyajima Eiji, Maesaki Shighefumi, Hashikita Giichi, Horii Toshinobu, Sumitomo Midori, Yoshimura Hitoshi, Hiraoka Minoru, Wada Hideo, Yuzuki Yosuke, Ikeda Norio, Baba Hisashi, Soma Masayuki, Yamamoto Tsuyoshi, Ichiyama Satoshi, Kinosita Syohiro, Kawano Seiji, Fujita Shinichi, Kageoka Takeshi, Hongo Toshiharu, Okabe Hidetoshi, Tatewaki Kenichi, Moro Kunihiko, Oka Mikio, Niki Yoshihito, Yoshida Haruyoshi, Yamashita Masanobu, Kusano Nobuchika, Mihara Eiichiro, Nose Motoko, Fushiwaki Takeshi, Kuwabara Masao, Fujiue Yoshihiro, Shimuzu Akira, Takubo Takayuki, Kusakabe Tadashi, Hinoda Yuji, Tanaka Nobuaki, Takahashi Hakuo, Heijyou Hitoshi, Okazaki Toshiro, Asai Koji, Kawahara Kunimitsu, Masuda Junichi, Sano Reiko, Taminato Tomohiko, Negayama Kiyoshi, Matsuo Syuji, Komatsu Masaru, Sugiura Tetsuro, Murase Mitsuharu, Hiramatsu Kazufumi, Yamane Nobuhisa, Nakasone Isao, Hirakata Yoichi, Kohno Shigeru, Aizawa Hisamichi, Honda Junichi, Hamazaki Naotaka, Okayama Akihiko, Ono Junko, Aoki Yosuke, Okada Kaoru, Miyanohara Hiroaki

机构信息

Department of Microbiology and Infectious Diseases, Toho University Faculty of Medicine.

出版信息

Jpn J Antibiot. 2006 Dec;59(6):428-51.

PMID:
17334061
Abstract

A total of 18,639 clinical isolates in 19 species collected from 77 centers during 2004 in Japan were tested for their susceptibility to fluoroquinolones (FQs) and other selected antibiotics. The common respiratory pathogens, Streptococcus pyogenes, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae showed a high susceptible rate against FQs. The isolation rate of beta lactamase non-producing ampicillin-resistant H. influenzae was approximately three times as large as those of western countries. Most strains of Enterobacteriaceae were also susceptible to FQs. The resistance rate of Escherichia coli against FQs has however been rapidly increasing so far as we surveyed since 1994. The FQs-resistant rate in methicillin-resistant Staphylococcus aureus (MRSA) showed approximately 90% except for 36%. of sitafloxacin while FQs-resistant rate in methicillin-susceptible S. aureus (MSSA) was around 5%. The FQs-resistant rate of methicillin-resistant coagulase negative Staphylococci (MRCNS) was also higher than that of methicillin-susceptible coagulase negative Staphylococci (MSCNS), however, it was lower than that of MRSA. In Pseudomonas aeruginosa clinical isolates, 32-34% from UTI and 15-19% of from RTI was resistant to FQs. Acinetobacter spp. showed a high susceptibility to FQs. Although FQs-resistant Neisseria gonorrhoeae have not been increased in western countries, it is remarkably high in Japan. In this survey, isolates of approximately 85% was resistant to FQs.

摘要

2004年期间,从日本77个中心收集了19个菌种的总共18639株临床分离菌,检测了它们对氟喹诺酮类药物(FQs)和其他选定抗生素的敏感性。常见呼吸道病原体化脓性链球菌、肺炎链球菌、卡他莫拉菌和流感嗜血杆菌对FQs显示出高敏感率。不产β-内酰胺酶的氨苄西林耐药流感嗜血杆菌的分离率约为西方国家的三倍。大多数肠杆菌科菌株也对FQs敏感。然而,自1994年我们开展调查以来,大肠杆菌对FQs的耐药率一直在迅速上升。耐甲氧西林金黄色葡萄球菌(MRSA)对FQs的耐药率除司帕沙星为36%外显示约为90%,而甲氧西林敏感金黄色葡萄球菌(MSSA)对FQs的耐药率约为5%。耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)对FQs的耐药率也高于甲氧西林敏感凝固酶阴性葡萄球菌(MSCNS),然而,低于MRSA。在铜绿假单胞菌临床分离株中,32%-34%的泌尿道感染分离株和15%-19%的呼吸道感染分离株对FQs耐药。不动杆菌属对FQs显示出高敏感性。虽然西方国家耐FQs淋病奈瑟菌未增加,但在日本其比例非常高。在本次调查中,约85%的分离株对FQs耐药。

相似文献

1
[In-vitro susceptibilites to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004].2004年从77个中心获得的18639株临床分离菌对左氧氟沙星及多种抗菌药物的体外敏感性
Jpn J Antibiot. 2006 Dec;59(6):428-51.
2
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007].[2007年从72个中心获得的12919株临床分离株对左氧氟沙星及多种抗菌药物的体外敏感性]
Jpn J Antibiot. 2009 Aug;62(4):346-70.
3
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].[2010年从72个中心获得的12866株临床分离株对左氧氟沙星及多种抗菌药物的体外敏感性]
Jpn J Antibiot. 2012 Jun;65(3):181-206.
4
[In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002].[2002年从52个中心获得的11475株临床分离菌对左氧氟沙星及多种抗菌药物的体外敏感性]
Jpn J Antibiot. 2005 Feb;58(1):17-44.
5
[Surveillance of in vitro susceptibilities to levofloxacin and various antibacterial agents for 11,762 clinical isolates obtained from 69 centers in 2013].2013年对来自69个中心的11762株临床分离菌株进行左氧氟沙星及多种抗菌药物体外药敏监测
Jpn J Antibiot. 2016 Feb;69(1):1-25.
6
[Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].[2000年日本37家医疗机构8474株临床分离菌株的抗菌药物活性]
Jpn J Antibiot. 2003 Oct;56(5):341-64.
7
Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002.日本全国范围内临床分离菌株中氟喹诺酮类及其他抗菌药物敏感性趋势调查:1994年至2002年的纵向分析
Diagn Microbiol Infect Dis. 2005 Jun;52(2):135-43. doi: 10.1016/j.diagmicrobio.2005.02.009.
8
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).多利培南(S-4661)的抗菌活性:一项全球监测报告(2003年)
Clin Microbiol Infect. 2005 Dec;11(12):974-84. doi: 10.1111/j.1469-0691.2005.01271.x.
9
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.通过药敏试验和时间杀菌试验比较加替沙星与其他药物对金黄色葡萄球菌、化脓性链球菌及呼吸道病原体的活性。
J Antimicrob Chemother. 2003 Nov;52(5):869-72. doi: 10.1093/jac/dkg429. Epub 2003 Sep 30.
10
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].左氧氟沙星及其他抗生素对新鲜临床分离株的体外活性
Jpn J Antibiot. 1999 Sep;52(9):571-84.

引用本文的文献

1
Efficacy and Safety of Sitafloxacin in the Treatment of Acute Bacterial Infection: A Meta-analysis of Randomized Controlled Trials.西他沙星治疗急性细菌感染的疗效与安全性:随机对照试验的荟萃分析
Antibiotics (Basel). 2020 Mar 2;9(3):106. doi: 10.3390/antibiotics9030106.